At a glance
ClinicalIndex Comparison RecordN/ACompleted· 155 enrolled
Drug / intervention
ICE Image guidancedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Philips (VeriSight) Intracardiac Echocardiography (ICE) Registry
In Brief
An observational study evaluating ICE Image guidance for Atrial Fibrillation and 7 related conditions. Completed, enrolled 155 participants across 5 sites.
Detailed Summary
The purpose of this observational registry is to report real-world safety and performance of VeriSight for ultrasound guided ICE imaging in percutaneous cardiac intervention procedures when used in standard clinical practice.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAtrial Fibrillation, Stroke, Valve Disease, Heart, Atrial Septal Defect, Patent Foramen Ovale, Mitral Valve Disease, Tricuspid Valve Disease, Aortic Valve Disease
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
First PostedJul 2021
Enrollment StartOct 2021
Primary CompletionDec 2022
Study CompletionJul 2023
TodayJul 2026
First PostedJul 6, 2021
Enrollment StartOct 25, 2021
Primary CompletionDec 30, 2022
Study CompletionJul 30, 2023
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 5.0 years ago
Interventions
ICE Image guidancedevice
ICE image guidance will be used on all patients undergoing planned cardiac catheterization procedures